Targeted alpha therapy of ovarian cancer with 212Pb-labeled anti-PTK7 antibody: On-site 212Pb production and preclinical insights
{{output}}
Background: Targeted alpha therapy (TAT) is recognized as a promising approach for eradicating tumor micro-metastases, owing to its high linear energy transfer. These micro-metastases are often associated with elevated recurrence... ...
